*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Ciba-Geigy/NNP Ltd./NNP ]
and/CC 
[ Chiron/NNP Corp./NNP ]
said/VBD 
[ they/PRP ]
extended/VBD 
[ their/PRP$ offer/NN ]
for/IN 
[ Connaught/NNP BioSciences/NNP Inc./NNP ]
,/, valued/VBN at/IN 
[ 866/CD million/CD Canadian/JJ dollars/NNS ]
 (/( 
[ US$/$ 736/CD million/CD ]
 )/) to/TO 
[ Oct./NNP 27/CD ]
./. 

======================================

[ The/DT companies/NNS ]
earlier/RBR said/VBD 
[ they/PRP ]
did/VBD n't/RB want/VB to/TO raise/VB 
[ their/PRP$ offer/NN ]
to/TO match/VB 
[ a/DT rival/JJ bid/NN ]
by/IN 
[ Institut/NNP Merieux/NNP S.A./NNP ]
of/IN 
[ C$/$ 37/NNP/CD ]

[ a/DT share/NN ]
,/, or/CC 
[ C$/$ 942/CD million/CD ]
./. 

But/CC 
[ they/PRP ]
said/VBD 
[ the/DT C$/$ 30-a-share/JJ bid/NN ]
,/, 
[ which/WDT ]
was/VBD due/JJ to/TO expire/VB 
[ Monday/NNP ]
,/, may/MD still/RB be/VB extended/VBN or/CC varied/VBN ./. 

======================================

[ Merieux/NNP ]
,/, 
[ a/DT vaccine/NN manufacturer/NN ]
based/VBN in/IN 
[ Lyon/NNP ]
,/, 
[ France/NNP ]
,/, is/VBZ 
[ 51%-held/JJ ]
by/IN 
[ French/JJ state-owned/JJ Rhone-Poulenc/NNP S.A./NNP Ciba-Geigy/NNP ]
is/VBZ 
[ a/DT major/JJ pharmaceutical/JJ concern/NN ]
based/VBN in/IN 
[ Basel/NNP ]
,/, 
[ Switzerland/NNP ]
./. 

[ Chiron/NNP ]
,/, 
[ another/DT pharmaceutical/JJ concern/NN ]
,/, is/VBZ based/VBN in/IN 
[ Emeryville/NNP ]
,/, 
[ Calif/NNP ]
./. 

[ Connaught/NNP ]
is/VBZ 
[ a/DT biotechnology/NN research/NN ]
and/CC 
[ vaccine/NN manufacturing/NN concern/NN ]
./. 

======================================

[ Institut/NNP Merieux/NNP 's/POS bid/NN ]
for/IN 
[ Toronto-based/JJ Connaught/NNP ]
has/VBZ run/VBN into/IN 
[ problems/NNS ]
with/IN 
[ the/DT Canadian/JJ government/NN ]
,/, 
[ which/WDT ]
told/VBD 
[ Merieux/NNP last/JJ week/NN ]
that/IN 
[ it/PRP ]

[ was/VBD n't/RB ]
convinced/VBN that/IN 
[ the/DT proposed/JJ acquisition/NN ]
would/MD be/VB of/IN ``/`` 
[ net/JJ benefit/NN ]
''/'' to/TO 
[ Canada/NNP ]
./. 

[ Merieux/NNP officials/NNS ]
are/VBP expected/VBN to/TO meet/VB with/IN 
[ federal/JJ officials/NNS ]
in/IN 
[ Ottawa/NNP today/NN ]
to/TO discuss/VB 
[ the/DT decision/NN ]
./. 
